Blue Horseshoe Stocks: EBIO, HRB Updates & More

H&R Block, Inc. HRB – Options Update

The options idea we formulated and passed along to our readers on Friday for HRB was far away our best play of the week, and an excellent way to wrap it up. Our specific target range that we highlighted in this case was the HRB 06/17 $21-23 Calls. and we ended up seeing monstrous moves out of each of the contained contracts.

$21 Calls – Trading Range: .60-3.30 – Max Gain: 450%
$22 Calls – Trading Range: .15-2.30 – Max Gain: 1430%
$23 Calls– Trading Range: .05-1.30 – Max Gain: 2500%

______

Added Reminder:

The other options play we set our sights on in Friday morning’s report was Global Blood Therapeutics,Inc. GBT – 06/17 $20-30 Calls. We saw some moderate activity as the stock ran early in the day, before tapering off. As they don’t expire until the end of this week, we just wanted to reiterate the possibility of more pronounced moves if GBT maintains support at 22.00 or above.


Eleven Biotherapeutics, Inc. EBIO 

The last time we reminded folks about our interest in EBIO, a stock that has appeared in our reports many times in the past, was on June 3rd. On that day, we were commenting on an earlier alert we put out on it back in May while EBIO’s PPS was at .80, after seeing it run up to its then-high of 2.10.

It ended up topping out at 2.60 on the afternoon of the 3rd, and has since been under light consolidation. It reached a support level of 1.62 on Friday, before beginning to rebound, and this morning it has gapped up hard in the premarket to a new high of 3.55 on the strength of an attractive PR (link below).

From our observed low in May, it represents an overall increase of 344% We’ll want to see the stock’s previous resistance level of 2.60 hold as support on any early pullbacks.


Extended Watchlist:
AROPQ, EXAD, TRQ, GIG, AMRS, QURE,
FLXN(Big Insider Buying)